Furthermore, other retrospective studies have reported real‐world outcomes of pembrolizumab (or other ICIs) alone or in combination with platinum‐based chemotherapy for advanced NSCLC with high PD‐L1 expression.7, 8, 9. Here, CD274 is linked to non-small cell lung carcinoma.